Login / Signup

Posttransplant lymphoproliferative disorder in a kidney transplant recipient: a case of Epstein-Barr virus-positive primary central nervous system lymphoma.

Hassam AliSyed Hamza Bin WaqarMarwan MajeedAlina SeharAqsa Mumtaz
Published in: Encephalitis (Seoul, Korea) (2022)
Posttransplant lymphoproliferative disorders (PTLDs) are potentially life-threatening complications of chronic immunosuppression in patients who receive solid organ transplants or allogeneic hematopoietic cell transplantation. Most PTLD cases are associated with Epstein-Barr virus (EBV) serology, and their incidence is typically higher in the first year of transplantation. Isolated EBV-positive diffuse large-cell B-cell lymphoma in the renal transplant setting has rarely been reported. Isolated EBV-positive primary central nervous system lymphoma (PCNSL) is rare, even in renal transplant patients with chronic immunosuppression. We report a case of frontal lobe EBV-positive PCNSL in a renal transplant patient who presented with left-sided weakness and was later treated with a consolidated chemotherapeutic regimen without concurrent radiotherapy.
Keyphrases
  • epstein barr virus
  • diffuse large b cell lymphoma
  • risk factors
  • bone marrow
  • cell therapy
  • early stage
  • stem cells
  • radiation therapy
  • single cell
  • low dose
  • high grade